BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26602164)

  • 21. Inhibiting CXCL12 blocks fibrocyte migration and differentiation and attenuates bronchiolitis obliterans in a murine heterotopic tracheal transplant model.
    Harris DA; Zhao Y; LaPar DJ; Emaminia A; Steidle JF; Stoler M; Linden J; Kron IL; Lau CL
    J Thorac Cardiovasc Surg; 2013 Mar; 145(3):854-61. PubMed ID: 22626514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cooperation between human fibrocytes and endothelial colony-forming cells increases angiogenesis via the CXCR4 pathway.
    Smadja DM; Dorfmüller P; Guerin CL; Bieche I; Badoual C; Boscolo E; Kambouchner M; Cazes A; Mercier O; Humbert M; Gaussem P; Bischoff J; Israël-Biet D
    Thromb Haemost; 2014 Nov; 112(5):1002-13. PubMed ID: 25103869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperpolarized (3)He ventilation defects used to predict pulmonary exacerbations in mild to moderate chronic obstructive pulmonary disease.
    Kirby M; Pike D; Coxson HO; McCormack DG; Parraga G
    Radiology; 2014 Dec; 273(3):887-96. PubMed ID: 24960283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating fibrocytes correlate with bronchiolitis obliterans syndrome development after lung transplantation: a novel clinical biomarker.
    LaPar DJ; Burdick MD; Emaminia A; Harris DA; Strieter BA; Liu L; Robbins M; Kron IL; Strieter RM; Lau CL
    Ann Thorac Surg; 2011 Aug; 92(2):470-7; discussion 477. PubMed ID: 21801908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
    Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD8 chemokine receptors in chronic obstructive pulmonary disease.
    Smyth LJ; Starkey C; Gordon FS; Vestbo J; Singh D
    Clin Exp Immunol; 2008 Oct; 154(1):56-63. PubMed ID: 18727632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating fibrocytes are involved in inflammation and leukocyte trafficking in neonates with necrotizing enterocolitis.
    Liu Y; Qingjuan S; Gao Z; Deng C; Wang Y; Guo C
    Medicine (Baltimore); 2017 Jun; 96(26):e7400. PubMed ID: 28658176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrocyte measurement in peripheral blood correlates with number of cultured mature fibrocytes in vitro and is a potential biomarker for interstitial lung disease in Rheumatoid Arthritis.
    Just SA; Lindegaard H; Hejbøl EK; Davidsen JR; Bjerring N; Hansen SWK; Schrøder HD; Hansen IMJ; Barington T; Nielsen C
    Respir Res; 2017 Jul; 18(1):141. PubMed ID: 28720095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antifibrotic effects of CXCR4 antagonist in bleomycin-induced pulmonary fibrosis in mice.
    Makino H; Aono Y; Azuma M; Kishi M; Yokota Y; Kinoshita K; Takezaki A; Kishi J; Kawano H; Ogawa H; Uehara H; Izumi K; Sone S; Nishioka Y
    J Med Invest; 2013; 60(1-2):127-37. PubMed ID: 23614921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of exacerbations on respiratory system impedance measured by a forced oscillation technique in COPD: a prospective observational study.
    Kamada T; Kaneko M; Tomioka H
    Int J Chron Obstruct Pulmon Dis; 2017; 12():509-516. PubMed ID: 28223791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-IgE therapy inhibits chemotaxis, proliferation and transformation of circulating fibrocytes in patients with severe allergic asthma.
    Wang CH; Weng CM; Huang TT; Lee MJ; Lo CY; Chen MC; Chou CL; Kuo HP
    Respirology; 2021 Sep; 26(9):842-850. PubMed ID: 34109713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
    Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CXCR4
    Jaffar J; Griffiths K; Oveissi S; Duan M; Foley M; Glaspole I; Symons K; Organ L; Westall G
    Respir Res; 2020 Aug; 21(1):221. PubMed ID: 32843095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum stromal-derived-factor-1 (CXCL12) and its alpha chemokine receptor (CXCR4) as biomarkers in neonatal sepsis.
    Badr HS; El-Gendy FM; Helwa MA
    J Matern Fetal Neonatal Med; 2018 Aug; 31(16):2209-2215. PubMed ID: 28562124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic utility of admission cell-free DNA levels in patients with chronic obstructive pulmonary disease exacerbations.
    Avriel A; Rozenberg D; Raviv Y; Heimer D; Bar-Shai A; Gavish R; Sheynin J; Douvdevani A
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3153-3161. PubMed ID: 28003743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the chemotactic factors for tumor-infiltrating fibrocytes and their prognostic significances in lung cancer.
    Tobiume M; Mitsuhashi A; Saijo A; Ogino H; Afroj T; Ogawa H; Goto H; Sato S; Abe A; Haji K; Ozaki R; Takizawa H; Nishioka Y
    Oncol Lett; 2022 Nov; 24(5):417. PubMed ID: 36245829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stability of the frequent COPD exacerbator in the general population: A Danish nationwide register-based study.
    Reilev M; Lykkegaard J; Halling A; Vestbo J; Søndergaard J; Pottegård A
    NPJ Prim Care Respir Med; 2017 Apr; 27(1):25. PubMed ID: 28416794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum CCL-18 level is a risk factor for COPD exacerbations requiring hospitalization.
    Dilektasli AG; Demirdogen Cetinoglu E; Uzaslan E; Budak F; Coskun F; Ursavas A; Ercan I; Ege E
    Int J Chron Obstruct Pulmon Dis; 2017; 12():199-208. PubMed ID: 28115842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased circulating fibrocytes are associated with higher reticulocyte percent in children with sickle cell anemia.
    Karafin MS; Dogra S; Rodeghier M; Burdick M; Mehrad B; Rose CE; Strieter RM; DeBaun MR; Strunk RC; Field JJ
    Pediatr Pulmonol; 2016 Mar; 51(3):295-9. PubMed ID: 26130026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis.
    Lange P; Çolak Y; Ingebrigtsen TS; Vestbo J; Marott JL
    Lancet Respir Med; 2016 Jun; 4(6):454-62. PubMed ID: 27061878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.